Identification of a novel Bcl‐xL phosphorylation site regulating the sensitivity of taxol‐ or 2‐methoxyestradiol‐induced apoptosis

[1]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[2]  C. Croce,et al.  Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Croce,et al.  Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. , 1996, Cancer research.

[4]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[5]  N. Hay,et al.  Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. , 1996, Cancer research.

[6]  T. Fojo,et al.  Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. , 1997, Cancer research.

[7]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[8]  M. Muda,et al.  Bcl-2 Undergoes Phosphorylation by c-Jun N-terminal Kinase/Stress-activated Protein Kinases in the Presence of the Constitutively Active GTP-binding Protein Rac1* , 1997, The Journal of Biological Chemistry.

[9]  C. Croce,et al.  Bcl2 is the guardian of microtubule integrity. , 1997, Cancer research.

[10]  W. May,et al.  Bcl-2 Phosphorylation Required for Anti-apoptosis Function* , 1997, The Journal of Biological Chemistry.

[11]  S. Fesik,et al.  Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2 , 1997, The EMBO journal.

[12]  P. Dent,et al.  Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). , 1998, Biochemical pharmacology.

[13]  C. Croce,et al.  Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. , 1998, Cancer research.

[14]  C. Rudin,et al.  Bcl-xL is phosphorylated in malignant cells following microtubule disruption. , 1998, Cancer research.

[15]  H. Adlercreutz,et al.  2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation. , 1998, Biochemical and biophysical research communications.

[16]  S. Haldar,et al.  The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. , 1998, Molecular human reproduction.

[17]  S. Haldar,et al.  Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. , 1998, International journal of oncology.

[18]  Kazuhito Yamamoto,et al.  BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M , 1999, Molecular and Cellular Biology.

[19]  P. Dent,et al.  Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL , 1999, Leukemia.

[20]  R. W. Janes,et al.  Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. , 1999, Journal of molecular biology.

[21]  P. Dent,et al.  Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. , 1999, Biochemical and biophysical research communications.

[22]  S. Korsmeyer,et al.  Cell Death in Development , 1999, Cell.

[23]  E. Alnemri.  Hidden powers of the mitochondria , 1999, Nature Cell Biology.

[24]  R. K Srivastava,et al.  Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Potter,et al.  Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells. , 2000, Cancer research.

[26]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[27]  E. White,et al.  p53 mediates Bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway , 2000, Oncogene.

[28]  R. Craig,et al.  Myeloid Cell Leukemia 1 Is Phosphorylated through Two Distinct Pathways, One Associated with Extracellular Signal-regulated Kinase Activation and the Other with G2/M Accumulation or Protein Phosphatase 1/2A Inhibition* , 2000, The Journal of Biological Chemistry.

[29]  Zhi-Min Yuan,et al.  Translocation of SAPK/JNK to Mitochondria and Interaction with Bcl-xL in Response to DNA Damage* , 2000, The Journal of Biological Chemistry.

[30]  S. Haldar,et al.  Regulation of Bcl2 phosphorylation by stress response kinase pathway. , 2000, International journal of oncology.

[31]  D. Kufe,et al.  Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells , 2001, Cell Death and Differentiation.

[32]  S. Capaccioli,et al.  Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase , 2001, Oncogene.

[33]  John C. Reed,et al.  Erratum: Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1 (Neoplasia (2001) 3 (550-559) , 2001 .

[34]  F. Shibasaki,et al.  Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2. , 2001, Journal of biochemistry.

[35]  R. K Srivastava.  TRAIL/Apo-2L: mechanisms and clinical applications in cancer. , 2001, Neoplasia.

[36]  M. Karin,et al.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.

[37]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. Shibasaki,et al.  Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells , 2002, Urological Research.

[39]  P. Cohen,et al.  Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[40]  D. Green,et al.  Remodeling for demolition: changes in mitochondrial ultrastructure during apoptosis. , 2002, Molecular cell.

[41]  S. Haldar,et al.  Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation. , 2002, Neoplasia.

[42]  E. Moon,et al.  Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells. , 2002, Cancer research.

[43]  R. Perez-soler,et al.  Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand. , 2002, Cancer research.

[44]  Richard A. Flavell,et al.  The Bax Subfamily of Bcl2-Related Proteins Is Essential for Apoptotic Signal Transduction by c-Jun NH2-Terminal Kinase , 2002, Molecular and Cellular Biology.

[45]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[46]  M. Landström,et al.  Mechanisms for 2‐methoxyestradiol‐induced apoptosis of prostate cancer cells , 2002, FEBS letters.

[47]  S. Hsu,et al.  Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells , 2002, Urological Research.

[48]  S. Haldar,et al.  2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells , 2002, Oncogene.

[49]  H. Ichijo,et al.  Phosphorylation and Inactivation of Myeloid Cell Leukemia 1 by JNK in Response to Oxidative Stress* , 2002, The Journal of Biological Chemistry.